Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa

Thumbnail Image

Files

434.pdf (1.27 MB)

Date

2022-10-03

Document type

journal article

Collections

Investigación
Total downloads31
Total views0
Bibliographic managers

Authors

Contreras-Gomez, María Jose, W. Martínez, Jose R., Rivas, Lina, Riquelme-Neira, Roberto, Ugalde, Juan A., Wozniak, Aniela, Garcia, Patricia, Munita, Jose M., Olivares-Pacheco, Jorge, Alcalde-Rico, Manuel

Publisher

FRONTIERS MEDIA SA

URI

https://repositorio.udla.cl/handle/udla/1439

DOI

https://doi.org/10.3389/fphar.2022.1007162

Keywords

ceftazidime/avibactam, cefotolozane/tazobactam, RND efflux pump, baseline susceptibility, carbapenem resistant Pseudomonas aeruginosa

Citation

Frontiers in Pharmacology, 13, 1007162. https://doi.org/10.3389/fphar.2022.1007162

Abstract

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is one of the pathogens that urgently needs new drugs and new alternatives for its control. The primary strategy to combat this bacterium is combinin...

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Creative Commons Attribution 4.0 International
Except where otherwised noted, this item's license is described as Creative Commons Attribution 4.0 International
Usage statistics
01345
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26